Reports by Industry
Reports by Company
- Company Analysis(173)
- Company Profile(60)
Global Cancer Generics Market Forecast to 2022
Format : 
Adobe Reader (PDF) Upto 24 hour delivery
Publish Date : Oct, 2016| No. of Pages : 110
Please make your selection :
Electronic Access - Single User License
US$ 1400.00
CD-ROM Mail Delivery
US$ 1600.00
Hard Copy Mail Delivery
US$ 1600.00
Electronic Access - Multi-User License
US$ 2000.00
1. Analyst View
2. Research Methodology
3. Global Cancer Drugs Market Outlook 2022
3.1 Cancer Incidences
3.2 Cancer Drug Market
4. Market Drivers & Challenges
4.1 Drivers
4.1.1 Increasing Cancer Incidences
4.1.2 Strategic Collaborations
4.1.3 Growing Geriatric Population
4.1.4 Ability to Curb Healthcare Cost
4.2 Challenges
4.2.1 Growing Backlog of Generic Drug Applications
4.2.2 Counterfeit Generic Drugs
4.3 Opportunities
4.3.1 Patent Expiry of Blockbuster Oncology Drugs
4.3.2 Generic Cancer Drugs Made More Accessible to Developing Countries
5. Global Cancer Generics Market Analysis 2022
6. Global Cancer Generics Market by Mode of Administration
6.1 Oral Generics
6.1.1 Arimidex (Anastrozole)
6.1.2 Femara (Letrozole)
6.1.3 Hycamtin (Topotecan)
6.1.4 Stivarga (Regorafenib)
6.1.5 Tarceva (Erlotinib)
6.1.6 Xalkori (Crizotinib)
6.1.7 Xeloda (Capecitabine)
6.1.8 Gleevec/Glivec (Imatinib Mesylate)
6.1.9 Nolvadex (Tamoxifen Citrate)
6.1.10 Targretin (Bexarotene)
6.2 Injectables Generics
6.2.1 Camptosar (Irinotecan Hydrochloride)
6.2.2 Eloxatin (Oxaliplatin)
6.2.3 Gemzar (Gemcitabine Hydrochloride)
6.2.4 Navelbine (Vinorelbine Tartrate)
6.2.5 Platinol (Cisplatin)
6.2.6 Taxol (Paclitaxel)
6.2.7 Taxotere (Docetaxel)
6.2.8 Fusilev (Levoleucovorin)
6.2.9 Ellence (Epirubicin Hydrochloride)
6.2.10 Adriamycin (Doxorubicin Hydrochloride)
7. Global Cancer Generics Market by Major Indications
7.1 Lung Cancer
7.2 Breast Cancer
7.3 Colorectal Cancer
7.4 Stomach Cancer
7.5 Prostate Cancer
8. Global Cancer Generics Market by Geographic Regions
8.1 US
8.2 Europe
8.3 Asia-Pacific
9. Trends & Developments
9.1 Generic Version of Blockbuster Cancer Drug
9.2 Entry of Indian Generic Cancer Drug in US
10. Mergers & Acquisitions
11. Key Players
11.1 Fresenius Kabi AG
11.2 Pfizer Inc
11.3 Teva Pharmaceutical Industries Ltd
11.4 Mylan N.V
11.5 Sun Pharmaceutical Industries Ltd
11.6 Sandoz International GmbH - A Novartis Company
11.7 Sanofi
11.8 Dr. Reddy's Laboratories Ltd
11.9 Cipla Ltd
11.10 Apotex Inc
Not able to find data you are looking for? Ask our Research Analyst.
media citation
- testtest
19 Jan, 2024 - Yourstory.com News @ Foodtech startup Swiggy launches Health Hub in Chennai
23 Mar, 2021 - Yourstory.com News @ Zomato forays into dietary supplements, makes its own 'made in India' brand
16 Mar, 2021 - View more
get in touch
Copyright © 2018, RNCOS, 2002-2018
About Us
Terms & Policy
Contact